Search tips
Search criteria 


Logo of aapspharmspringer.comThis journalToc AlertsSubmit OnlineOpen Choice
AAPS PharmSciTech. 2006 March; 7(1): E138–E145.
Published online 2006 March 10. doi:  10.1208/pt070120
PMCID: PMC2750727

Evaluation of the TSI aerosol impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers


The purpose of this research was to evaluate a redesigned impactor stage for the TSI Model 3306 Impactor Inlet with nozzles adjusted to obtain a target cut-point of 4.7 μm. It has been determined that the previous cut-point used in the Model 3306 was nominally closer to 4.14 μm, thus potentially impacting the characterization of aerosol mass. The reassessment of the Model 3306 was performed on 4 solution and 2 suspension metered-dose inhaler (MDI) formulations. The redesigned impactor stage resulted in a 5% to 6% increase in aerosol mass when compared with the previous impactor stage for the products Ventolin-HFA, Proventil-HFA, and 2 cyclosporin solution formulations with high ethanol concentrations (15% wt/wt). For the formulations with low ethanol concentrations (3% wt/wt), minimal differences were observed between the 2 cut-points. In addition, this study reevaluated the requirement of a vertical inlet extension length when using the TSI 3306/3321 system with the redesigned cut-point. It was shown that the use of a 20-cm extension provides mass and aerosol size distributions that are comparable to the Andersen 8-stage Cascade Impactor, for both solution and suspension MDIs. This work indicates that the TSI 3306/3321 system is suitable for preformulation studies of both suspension and solution MDI systems.

Keywords: aerosols, metered-dose inhalers, particle sizer, size distribution

Full Text

The Full Text of this article is available as a PDF (342K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
1. Mitchell JP, Nagel MW, Wiersema KJ, Doyle CC. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer. AAPS PharmSciTech. 2003;4:E54–E54. doi: 10.1208/pt040454. [PMC free article] [PubMed] [Cross Ref]
2. Mogalian E, Myrdal PB, Application of USP inlet extensions to the TSI impactor system 3306/3320 using HFA 227 based solution metered dose inhalers. Drug Dev Ind Pharm. [PubMed]
3. Wachtel H, Zeigler J. Improved assessment of inhaler device performance using laser diffraction. Respiratory Drug Delivery VIII. 2002;2:379–381.
4. Wachtel H, Ziegler J, inventors. Laser diffraction method for particle size distribution measurements in pharmaceutical aerosols. US patent 0142665. June 30, 2005.
5. Finlay WH, Stapleton KW. Undersizing of droplets from a vented nebulizer caused by aerosol heating during transit through an Andersen impactor. J Aerosol Sci. 1999;30:105–109. doi: 10.1016/S0021-8502(98)00024-X. [Cross Ref]
6. Ding JY, McVeety BD, Busick DR, Miller PR, Zimlich WC, Placke ME. Correlation of particle size distribution measurements between optical and inertial impaction techniques using an ethanolic drug formulation for inhalation. Respiratory Drug Delivery VIII. 2002;2:355–358.
7. Holmes CE, Kippax PG, Newell HE, Southhall JP, Ward DJ. Simultaneous analysis of respirable aerosols via laser diffraction and cascade impaction. London, UK: The Aerosol Society; 2001. pp. 58–61.
8. Smyth HDC, Hickey AJ. Comparative particle size analysis of solution propellant driven metered dose inhalers using cascade impaction and laser diffraction. Respiratory Drug Delivery VIII. 2002;2:731–734.
9. Haynes A, Shaik MS, Krarup H, Singh M. Evaluation of the Malvern Spraytec with inhalation cell for the measurement of particle size distribution from metered dose inhalers. J Pharm Sci. 2004;93:349–363. doi: 10.1002/jps.10558. [PubMed] [Cross Ref]
10. Corcoran TE, Hitron R, Humphrey W, Chigier N. Optical measurement of nebulized sprays: a quantitative comparison of diffraction, phase Doppler interferometry, and time-of-flight analysis. J Aerosol Sci. 2000;31:35–50. doi: 10.1016/S0021-8502(99)00030-0. [Cross Ref]
11. Stein SW, Gabrio BJ, Oberreit D, Hairston P, Myrdal PB, Beck TJ. An evaluation of mass-weighted size distribution measurements with the model 3320 aerodynamic particle sizer. J Aerosol Med. 2003;16:107–119. doi: 10.1089/089426803321919870. [PubMed] [Cross Ref]
12. Myrdal PB, Stein SW, Mogalian E, Hoye WL, Gupta A. Comparison of the TSI model 3306 impactor inlet with the Andersen cascade impactor: solution metered dose inhalers. Drug Dev Ind Pharm. 2004;30:859–868. doi: 10.1081/DDC-200034575. [PubMed] [Cross Ref]
13. Marple VA. A Fundamental Study of Inertial Impactors. Minneapolis, MN: University of Minnesota, Particle Technology Laboratory-Publication; 1970.
14. Hinds WC. Aerosol Technology. New York, NY: John Wiley & Sons; 1999.
15. Rader DJ, Marple VA. A study of the effects of anisokinetic sampling. Aerosol Sci Technol. 1988;8:283–299. doi: 10.1080/02786828808959190. [Cross Ref]
16. Hickey AJ, Dalby RN, Byron PR. Effects of surfactants on aerosol powders in suspension: implications for airborne particle size. Int J Pharm. 1988;42:267–270. doi: 10.1016/0378-5173(88)90186-X. [Cross Ref]
17. Vaughan NP. The Andersen impactor: calibration, wall losses and numerical simulation. J Aerosol Sci. 1989;20:67–90. doi: 10.1016/0021-8502(89)90032-3. [Cross Ref]
18. Stein SW, Olson BA. Variability in size distribution measurements obtained using multiple Andersen mark II cascade impactors. Pharm Res. 1997;14:1718–1725. doi: 10.1023/A:1012175612193. [PubMed] [Cross Ref]
19. Stein SW, Myrdal PB. A theoretical and experimental analysis of formulation and device parameters affecting solution MDI size distributions. J Pharm Sci. 2004;93:2158–2175. doi: 10.1002/jps.20116. [PubMed] [Cross Ref]
20. Gupta A, Stein SW, Myrdal PB. Balancing ethanol cosolvent concentration with product performance in 134a-based pressurized metered dose inhalers. J Aerosol Med. 2003;16:167–174. doi: 10.1089/089426803321919924. [PubMed] [Cross Ref]

Articles from AAPS PharmSciTech are provided here courtesy of American Association of Pharmaceutical Scientists